Beyond the clinical setting, the study advocates for a shift in public health messaging. As more regions move toward legalizing cannabis, the researchers believe that public information campaigns should be updated to reflect these findings. They suggest that the potential connection with violence should be included alongside other known health risks, such as the impact on lung health or cognitive function, to ensure that consumers can make fully informed decisions.
However, the team at King’s College London was careful to frame these findings within the context of scientific uncertainty. They emphasized that while the review identifies a clear and significant association, it does not provide definitive proof that cannabis use directly causes violence. The relationship is likely influenced by a complex web of "confounding factors." Cannabis use frequently occurs alongside other behaviors and circumstances that are independently linked to violence. These include the use of alcohol or other illicit drugs, as well as difficult social and economic circumstances, such as poverty or lack of social support. Distinguishing the exact role of cannabis from these other variables remains a challenge for researchers.
Important Limitations
The review also acknowledged several limitations that provide context for the findings and suggest directions for future research. One primary concern is the lack of detailed data regarding "dosage." Only a small fraction of the 63 studies analyzed actually measured the quantity of cannabis consumed or the frequency of use. Without this data, it is difficult to determine if there is a "threshold" of use that triggers a higher risk of violence, or if the risk scales linearly with consumption.
Additionally, the findings related to criminal convictions were based on a relatively small subset of the total studies reviewed. While the three-to-fourfold increase in conviction risk is statistically significant, the researchers noted that more data is needed to solidify this specific connection.
Perhaps the most pressing limitation involves the changing nature of the drug itself. The majority of the research included in the meta-analysis was conducted years ago, before the widespread availability of high-potency cannabis products. Modern cannabis often contains much higher levels of THC (tetrahydrocannabinol), the primary psychoactive component, and lower levels of CBD (cannabidiol), which is thought to have some antipsychotic properties.
The researchers suggested that the daily use of today’s more potent cannabis could potentially be associated with even stronger effects than those observed in the older studies. This "potency gap" means that the current risks to public health might be underestimated by historical data.
The study received support from the National Institute for Health and Care Research (NIHR) Biomedical Research Centre at Maudsley and the Medical Research Council. As the debate over cannabis policy continues to evolve globally, this review provides a substantial new body of evidence for policymakers, clinicians, and the public to consider when weighing the social and personal costs of use. The researchers conclude that while cannabis is often perceived as a relaxing or sedative substance, its association with violence and victimization is a reality that can no longer be overlooked in the interest of public safety.
